Company Performance Metrics
- Franco Cescotti: CEO
Dharma Bioscience is at the forefront of developing an innovative injectable treatment utilizing modified microRNAs to promote cartilage regeneration in patients with osteoarthritis. This advanced therapy offers a straightforward administration method for physicians worldwide, reducing the necessity for invasive joint replacement surgeries. By
providing a non-invasive alternative, this injectable solution not only minimizes recovery time and associated costs but also presents patients with a safer and more accessible option for managing their condition.